drugset / Trial / NCT06483659

Intravenous Oxytocin for Post Operative Pain After Minimally Invasive Hysterectomy

NCT06483659

Phase 2 Recruiting 152 enrolled Brigham and Women's Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a randomized, double-blinded, placebo-controlled trial to compare the effectiveness of IV oxytocin infusion to placebo on peri-operative opioid consumption and reducing post-operative pain following a minimally invasive hysterectomy under general anesthesia.

Timeline

Start
2025-06-01
Primary completion
2026-07-01
Completion
2026-12-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Oxytocin Peptide 30 iu Intravenous

Indications

No indication recorded.